Growth Metrics

Dexcom (DXCM) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -4.46%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 363.84%
Dec 31, 2025 8.65%
Sep 30, 2025 556.17%
Jun 30, 2025 -2.06%
Mar 31, 2025 -36.44%
Dec 31, 2024 118.00%
Sep 30, 2024 -59.64%
Jun 30, 2024 62.45%
Mar 31, 2024 88.72%
Dec 31, 2023 17.54%
Sep 30, 2023 18.27%
Jun 30, 2023 61.50%
Mar 31, 2023 363.73%
Dec 31, 2022 169.53%
Sep 30, 2022 32.90%
Jun 30, 2022 305.30%
Mar 31, 2022 57.44%
Dec 31, 2021 -77.10%
Sep 30, 2021 38.92%
Jun 30, 2021 -141.29%
Mar 31, 2021 -129.71%
Dec 31, 2020 12.25%
Sep 30, 2020 123.66%
Jun 30, 2020 444.89%
Mar 31, 2020 -13.82%
Dec 31, 2019 522.50%
Sep 30, 2019 35.76%
Jun 30, 2019 -43.41%
Mar 31, 2019 -14.58%
Dec 31, 2018 -32.20%
Sep 30, 2018 45.37%
Jun 30, 2018 1,252.17%
Mar 31, 2018 -6.19%
Dec 31, 2017 648.84%
Sep 30, 2017 228.99%
Jun 30, 2017 -76.04%
Mar 31, 2017 -93.16%
Dec 31, 2016 -1,333.33%
Sep 30, 2016 -34.29%
Jun 30, 2016 -4.95%
Mar 31, 2016 -154.35%
Dec 31, 2015 -107.89%
Sep 30, 2015 36.36%
Jun 30, 2015 359.09%
Mar 31, 2015 26.98%
Dec 31, 2014 80.95%
Sep 30, 2014 1,383.33%
Jun 30, 2014 300.00%
Mar 31, 2014 -6.78%
Dec 31, 2013 117.50%
Sep 30, 2013 93.26%
Jun 30, 2013 88.04%
Mar 31, 2013 52.80%
Dec 31, 2012 20.46%
Sep 30, 2012 -7.92%
Jun 30, 2012 -149.59%
Mar 31, 2012 -12.82%
Dec 31, 2011 4.84%
Sep 30, 2011 28.68%